Super Sleeping
Super Sleeping, licence 80085595: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Dream Code - Deep Sleep
- Licence holder
- Aurora Biotechnology Canada Inc
- NPN or DIN-HM
- 80085595
- Status
- Active licence
- Licence date
- 28 May 2018
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide gamma-aminobutyrique Source : Acide glutamique | 135.0 milligramme | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 5.0 milligramme | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 2.0 milligramme | 2,000 µg |
| 5-Hydroxy-L-tryptophane Source : Griffonia simplicifolia, graine | 50.0 milligramme | Not calculated |
| 5-Hydroxy-L-tryptophane Source : 5-HTP | 50.0 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Maltodextrine, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
(1) Helps to temporarily promote relaxation. (2) Helps to increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule. (3) Helps to prevent and/or reduce the effects of jet lag (e.g. daytime fatigue, sleep disturbance) for people travelling by plane easterly across two or more time zones. (4) Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. (5) Helps to re-set the body¿s sleep-wake cycle (aspect of the circadian rhythm) (6) Source of vitamin, a factor in the maintenance of good health. (7) Source of vitamin, a factor in normal growth and development. (8) Source of vitamin to support biological functions which play a key role in the maintenance of good health. (9) Vitamin supplement. (10) Helps in energy metabolism and in tissue formation. (11) Helps to form red blood cells. (12) Helps to maintain the body's ability to metabolize nutrients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80085595
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.